h
Let’s Work Together
[email protected]

Meet Arrosa, the perfect theme to elevate your online presentation with.

Via Appia Antica,
224, 00179 Roma, Italy
+1 312 749 8649

Il mio account Area clienti
Contatto BTI Channel BTI Channel BTI Biotechnology Institute BTI Biotechnology Institute
Search here!

Articoli

Plasma rich in growth factors as treatment for a full-thickness macular hole due to macular telangiectasia type 2
  • Autore:
  • Rangel CM
  • Blanco NA
  • Pedraza-Concha A
  • Gomez MA
  • Parra MM
  • Arias JD
PMID: 35523468

Arch Soc Esp Oftalmol (Engl Ed). 2022 Apr;97(4):219-223. Full-thickness macular hole is a rare complication of macular telangiectasia type 2, and its treatment is still controversial. A patient with a full-thickness macular hole secondary to macular telangiectasia type 2 underwent vitreoretinal surgery with a plasma rich in growth factors membrane in the macular hole. At the sixth month of follow-up, anatomical and functional improvements were achieved, with no adverse effects.

Composite alginate-gelatin hydrogels incorporating PRGF enhance human dental pulp cell adhesion, chemotaxis and proliferation
PMID: 35247496

Int J Pharm. 2022 Apr 5:617:121631. The increasing prevalence of tissue injuries is fueling the development of autologous biological treatments for regenerative medicine. Here, we investigated the potential of three different bioinks based on the combination of gelatin and alginate (GA), enriched in either hydroxyapatite (GAHA) or hydroxyapatite and PRGF (GAHAP), as a favorable microenvironment for human dental pulp stem cells (DPSCs)

Plasma Rich in Growth Factors for Persistent Macular Hole: A Pilot Study
  • Autore:
  • Arias JD
  • Hoyos AT
  • Alcántara B
  • Sanchez-Avila RM
  • Arango FJ
  • Galvis V
PMID: 31895724

Retin Cases Brief Rep. 2022 Mar 1;16(2):155-160. Persistent macular hole (PMH) is a challenge for retina surgeons. There are limited surgical techniques described achieving PMH closure. For more than a decade, techniques with blood derivatives have been described without optimal outcomes. The aim of this article is to report the usefulness of the plasma rich in growth factors (PRGF) as a new way to improve PMH closure.

Current opinion on the role of vitamin D supplementation in respiratory infections and asthma/COPD exacerbations: A need to establish publication guidelines for overcoming the unpublished data
PMID: 35182989

Clin Nutr. 2022 Mar;41(3):755-777. The role of prophylactic vitamin D supplementation in prevention and treatment of respiratory infections and other related pathologies has been extensively explored with conflicting results. The aim of this systematic review and meta-analysis was to evaluate the prophylactic and therapeutic effects of vitamin D administration on respiratory infections.

Oral Lichen Planus Treated With Plasma Rich in Growth Factors
PMID: 35659139

Cutis. 2022 Mar;109(3):163-166. The use of plasma rich in growth factors (PRGF) is a treatment for erosive oral lichen planus (OLP) resistant to steroid therapy. An anonymous database at a clinical center was reviewed to collect demographic data, lesion type, treatment protocol, number of infiltrations, pain score, and healing time of the lesions.

Implant Dentistry from One-Way Direction to the Reversibility of the Osseointegration
PMID: 35176785

Eur J Dent. 2022 May;16(2):464.Nowadays, implant dentistry has social, economic, and clinical values. It is one of the economic motors of society. The reliability and high success rate of implant-based oral rehabilitation are fascinating, making this option predictable and safe.[1] However, dealing with an implant failure is frustrating for both clinicians and patients. For this reason, moving implant dentistry from a one-way direction to treatment reversibility would improve the management of failure cases with minimally invasive measures.

The inclusion of leukocytes into platelet rich plasma reduces scaffold stability and hinders extracellular matrix remodelling
  • Autore:
  • Eduardo Anitua
  • Mohammad H. Alkhraisat
  • Mar Zalduendo
  • María Troya
  • Roberto Tierno
PMID: 34767933

Ann Anat. 2022 Feb:240:151853. doi: 10.1016/j.aanat.2021.151853. Scaffolds should have controllable degradation rate and allow cells to produce their own extracellular matrix. Platelet rich plasma (PRP) is a source of autologous growth factors and proteins embedded in a 3D fibrin scaffold. There is no consensus regarding the obtaining conditions and composition of PRPs.

Plasma Rich in Growth Factors in Macular Hole Surgery
  • Autore:
  • Eduardo Anitua
  • Ronald M Sánchez-Ávila
  • Carlos A Robayo-Esper
  • Eva Villota-Deleu
  • Álvaro Fernández-Vega Sanz
  • Álvaro Fernández-Vega González
  • Borja de la Sen-Corcuera
  • Jesús Merayo-Lloves
PMID: 35076502

Clin Pract. 2022 Jan 10;12(1):57-69. The aim of this study was to evaluate the use of PRGF (plasma rich in growth factors) as an adjuvant to PPV (pars plana vitrectomy) in recurrent, persistent, or poor prognosis MH (macular hole). Patients with MH were treated with PPV plus adjuvant therapy (PRGF membrane (mPRGF) and injectable liquid PRGF (iPRGF)).

In vitro and in vivo Effect of Platelet-Rich Plasma-Based Autologous Topical Serum on Cutaneous Wound Healing
PMID: 34247175

Skin Pharmacol Physiol. 2022;35(1):51-64. Skin injury and wound healing is an inevitable event during lifetime. However, several complications may hamper the regeneration of the cutaneous tissue and lead to a chronic profile that prolongs patient recovery. Platelet-rich plasma is rising as an effective and safe alternative to the management of wounds